Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
PEPenumbra, Inc. logo

Penumbra, Inc. (PEN)

New York Stock Exchange · Currency in USD
$324.39 ▼ -0.57 (-0.18%)
At close: Oct 23, 4:00 PM ET. Market closed.
$322.31 ▼ -2.08 (-0.64%)
After hours: Oct 23, 6:30 PM ET

Summary

Previous Close
$324.96
Open
$325.67
Day's Range
$323.91 – $325.67
52 Week Range
$221.26 – $362.41
Volume
357,894
Avg. Volume
351,561
Market Cap
$12.78B
Beta (5Y Monthly)
0.70
PE Ratio (TTM)
79.31
EPS (TTM)
$4.08
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$320.00

Profile: Penumbra, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
4,700
CEO
Adam Elsesser

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate $1.20 · Revenue est. $401.41M
DateEst.Actual
Jul 30, 2026$1.16$0.88Miss
May 6, 2026$1.04$0.82Miss
Feb 25, 2026$1.11$1.18Beat
Nov 5, 2025$0.93$0.97Beat
Jul 29, 2025$0.81$0.86Beat
Apr 23, 2025$0.66$0.83Beat

Analyst view

Consensus price target
$320.00 ▼ -1.4%
Range $320.00 – $320.00
Rating: Hold
Buy 41% · Hold 59% · Sell -0%

Get free alerts on PEN and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.